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Background: Exercise testing is a valuable prognostic tool and exercise training has many health benefits in cystic fibrosis (CF). The objective of
this study was to survey the provision of exercise testing and training in UK CF clinics.
Methods: A three-page questionnaire was used to determine the extent of, scope and importance assigned to exercise testing and training.
Results: Data from returned questionnaires showed that 38.9% of paediatric and 27.8% of adult patients had performed an exercise test in the
preceding 12 months, most as part of an annual review process. Pulmonary rehabilitation programmes were accessible in only 31.3% of clinics,
and only 26.0% provide exercise training programmes. When assigning importance for exercise testing on a scale from 1 ‘not important’ to 5 ‘very
important’, the mean and median respondent scores were 3.5 and 4.0, respectively, and for the importance of training were 4.0 and 4.0,
respectively.
Conclusions: Despite the level of importance given to exercise testing and training by healthcare providers, exercise is underused as either an
assessment tool or therapeutic intervention in the healthcare of patients with CF in the UK.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Exercise; Healthcare; United Kingdom; Children; Adults1. Introduction
Exercise performance represents an integration of the
cardiopulmonary, loco-motor and metabolic systems. Psycho-
logical wellbeing and quality of life are inherently linked to an
individual's physical capability. Consequently, in a multi-
system disease such as cystic fibrosis (CF) the assessment of
exercise tolerance is clinically relevant. Indeed, aerobic fitness
measured by peak oxygen uptake (V ̇O2peak) during maximal
exercise is a strong predictor of survival [1–3]. In patients with
mild disease more sophisticated testing measuring pulmonary⁎ Corresponding author. Children's Health and Exercise Research Centre,
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ities in early disease [4].
Pulmonary rehabilitation (PR) is an intervention for patients
with symptomatic chronic respiratory disease limiting their
daily life activities. Its therapeutic role in chronic obstructive
pulmonary disease (COPD) for exacerbations and chronic
limitation is well established. More strenuous exercise training
requires engagement in a schedule of vigorous physical activity
and in CF may increase aerobic fitness [5,6], decrease the rate of
decline [7], or even improve lung function [8] and improve
quality of life scores [9]. A Cochrane review reported the
benefits of training programmes in CF including help in the
management of CF related diabetes mellitus, delay the onset of
osteoporosis, decreased anxiety and improved body image [10].
The UK CF Trust standards for clinical care (2001) recommend
that annual exercise testing and training should be undertaken,
but no details are provided [11]. The objective of this study was
to identify and quantify the scope of exercise testing andd by Elsevier B.V. All rights reserved.
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importance assigned by clinic staff.2. Methods
Questionnaires were sent to 186 UK CF clinics (137
paediatric and 49 adult) in 2008. These were identified from
the South and West CF Carers Regional Directory 2007 [12].
Centres were asked to confirm whether they were specialist
centres, [i.e., staffed by a multidisciplinary team with
appropriate expertise, usually caring for a minimum of 100
patients and providing comprehensive access to medical sub-
specialties and clinical investigations according to UK stan-
dards [11]] or shared care clinics which are smaller and where
patient care is supervised, supported and reviewed at least
annually by a networked specialist centre. The three-page
questionnaire requested information on the number of patients,
the professional role of the respondent, whether exercise testing
was used to evaluate patient health, equipment available, type of
tests used (specific protocols for cycle and treadmill testing,
however, were not requested), reasons for conducting testing,
and the number conducted for those reasons in the preceding
12 months. Also requested was who within the multi-disciplin-
ary team (MDT) supervised tests, whether availability of
personnel, facility or equipment limited testing, and enquired
as to what would enhance testing at the clinic. Information was
requested about who within the MDT discussed exercise
activity with patients, how often and the nature of advice
given. Availability and nature of PR and training programmes
were sought.
The importance assigned to exercise testing and training was
canvassed and quantified by a visual-analogue scale ranging
from 1 ‘not important at all’ to 5 ‘very important’.2.1. Ethical approval
The NHS Research Ethics Committee advised that as the
study was a survey on healthcare provision, an ethical review
was not required.Table 1
Availability of equipment for exercise testing to evaluate patient health in clinics.
Paediatric
Specialist centres Shared care clinics
Number of clinics 16 53
Equipment availability for exercise testing
Pulse oximeter a 14 (87.5%) 34 (64.2%)
Treadmill 9 (56.3%) 13 (24.5%)
Cycle 5 (31.3%) 6 (11.3%)
Electrocardiogram 4 (25.0%) 12 (22.6%)
Metabolic cart 1 (6.3%) 1 (1.9%)
None of the above 1 (6.3%) 15 (28.3%)
a The survey specifically enquired as to whether a pulse oximeter was availabl
measurements. Two shared care clinics commented that no pulse oximeter was avai2.2. Statistical analysis
Frequencies and descriptive statistics were used to analyse
data using the Statistical Package for Social Sciences (SPSS;
version 11.0, Chicago, IL).
3. Results
Questionnaires were returned from 96 clinics (response rate
51.6%). Returned questionnaires were completed by clinicians
(68.8%), physiotherapists (26.0%) and CF clinical nurse
specialists (CNS) (5.2%).
Our survey showed that 51 (53.1%) of responding CF clinics
use exercise testing to evaluate patient health. Over a 12 month
period in specialist centres 1440 and in shared care clinics 266
exercise tests were conducted. These results reveal that 43.3%
and 28.9% of children attending paediatric specialist and shared
care clinics, respectively, had undergone a test in the preceding
12 months, compared to 26.8% of adults in specialist and 50.4%
in shared care clinics. Data in Table 1 show the availability of
equipment for testing and data in Table 2 show the type of tests
used. Respondents from 45 clinics stated that the primary reason
that exercise testing was limited was due to resource availability.
Reasons included lack of personnel or their time (24.0%), lack of
facility and/or equipment (13.5%) and lack of both of these
(9.4%). On-line supplemental data accompanying this article
presents the reasons for exercise testing and which members of
the MDT supervise the tests (Supplementary data A), and
individual subjective respondent comments to enhance exercise
testing at clinics (Supplementary data B).
Overall, 82.2% of clinics discuss exercise activity at every
appointment. In 78.1% of clinics the advice given at any time
about exercise activity is only general encouragement, and in
only 16.6% did clinic staff make more specific individualised
recommendations. PR is accessible in 31.3% of clinics, mainly
in adult care and overall only 26.0% of clinics prescribe exercise
training programmes for patients. Further details including
frequency of discussion, advice given and who discusses
exercise activity with the patient, and provision of exercise
training programmes are available in the on-line supplemental
data accompanying this article (Supplementary data C).Adults
Specialist centres Shared care clinics Overall
20 7 96
18 (90.0%) 7 (100.0%) 73 (76.0%)
11 (55.0%) 2 (28.6%) 35 (36.5%)
10 (50.0%) 3 (42.9%) 24 (25.0%)
10 (50.0%) 3 (42.9%) 29 (30.2%)
2 (10.0%) 1 (14.3%) 5 (5.2%)
1 (5.0%) 0 17 (17.7%)
e for use in exercise testing beyond availability for resting oxygen saturation
lable in the outpatient setting at all.
Table 2
Type of exercise tests used to evaluate patient health in clinics.
Paediatric Adults
Specialist centres Shared care clinics Specialist centres Shared care clinics Overall
Number of clinics 16 53 20 7 96
Types of exercise tests used
6-minute walk testa, b, c 4 (25.0%) 5 (9.4%) 12 (60.0%) 2 (28.6%) 23 (24.0%)
12-minute walk testd, c 0 1 (1.9%) 1 (5.0%) 0 2 (2.1%)
Incremental shuttle walk testa, b, e, f 6 (37.5%) 10 (18.9%) 14 (70.0%) 5 (71.4%) 35 (36.5%)
Endurance shuttle walk testa, b, c 0 2 (3.8%) 1 (5.0%) 1 (14.3%) 4 (4.2%)
Step testa, b, c 8 (50.0%) 5 (9.4%) 5 (25.0%) 2 (28.6%) 20 (20.8%)
Treadmill testd, g, h,e 2 (12.5%) 6 (11.3%) 4 (20.0%) 1 (14.3%) 13 (13.5%)
Cycle testd, g, h, e 2 (12.5%) 1 (1.9%) 4 (20.0%) 1 (14.3%) 8 (8.3%)
N.B. these are recommendations made in the literature and by the authors, it is ultimately dependent on the judgement of the supervisor as to which exercise test would
be best suited to the patient.
a Recommended for assessing exercise limitation in advanced disease.
b Suitable for all ages.
c Test of endurance.
d Recommended for ages ∼8 years or above.
e Test of peak exercise performance.
f Incremental test.
g Typically includes the measurement of peak oxygen uptake.
h Gives an objective measure of peak performance.
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and training is shown in Fig. 1. Opinion from all respondents on
the need for exercise testing (mean and median) was 3.5 and
4.0, respectively, and on exercise training was 4.0 and 4.0,
respectively.
4. Discussion
The primary finding of this survey shows that exercise testing
and training is limited or underused in the healthcare of patients
with CF across the UK, despite the diagnostic and therapeutic
value of exercise being recognised by healthcare providers.
Similar conclusions were made from surveys investigating the
use of exercise testing and training in CF centres in the different
healthcare systems of the US and Germany [13,14]. Surveys in
the US and Germany reported that exercise testing is performed
in 43.5% and 63.0% of CF clinics, respectively. In our survey,Fig. 1. Importance assigned to exercise testing and training in the clinics (N.B.
missing data represent % of respondents who did not answer this question).53.1% of clinics reported that exercise testing was used,
however, the number of exercise tests performed over a 12
month period is lower (32.5%). In the US and Germany 21.7%
and 15.0% offer a tailored exercise training programme,
respectively, compared to 15.6% in our survey. Based on the
UK CF register [15] the responding specialist centre clinics
alone provide healthcare for at least 54.8% of UK patients with
CF. Surveys which do not offer inducements to return the
questionnaire have a response rate of ∼48.0% [16,17]. Where
inducements are offered, the response rate has been found to
increase to 75.0% [17], however for financial reasons induce-
ments were not an option, as was a second mailing to clinics.
Therefore, the survey response rate of 51.6% is considered a
limitation and raises the possibility of selection bias in the
reports returned. Non-responding clinics may use and favour
exercise less and thus may therefore lead to an over-estimation in
our findings of provision and the importance assigned to
exercise. It is not possible to say whether this could be counter-
balanced by any clinics supportive of exercise testing who were
unable to respond to the questionnaire. Physiotherapists in CF
teams may be more enthusiastic about exercise but were
responsible for only 26.0% of the questionnaires returned,
68.8% were completed by senior medical staff.
Paediatric CF care in the UK is less centralised than adult
care and it is noteworthy that the equipment for, use and scope
of exercise testing is significantly greater in adult than paediatric
clinics and in specialist centres than in shared care clinics. Adult
respiratory care is more burdened by chronic disease limiting
activity, especially COPD, for which PR services have evolved,
increasing awareness, expertise and ultimately availability of
services that may be accessible to the adult CF population.
Measures of peak performance and training which may have a
role in fitter or younger patients have limited availability. As a
therapeutic intervention, training ought to be equally accessible
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training is greater in specialist centres than shared care clinics.
Testing was reported to be limited by resource availability in
46.9% of clinics overall. Compared to the results of our survey,
CF clinics in Germany have greater availability of specialist
exercise equipment [14]. Our information suggests that in the
UK testing is rarely undertaken more than once a year or outside
of the annual review process for patients.
This survey confirms a lack of both standardisation and
provision of exercise testing and training with variability in the
availability of resources between clinics. An example of
variation in practice is that in two similarly sized adult specialist
CF centres (∼225 patients), one centre had the availability of
equipment to measure full cardiopulmonary variables during
cycle ergometry exercise and had conducted 146 exercise tests
in the previous year. The other centre only had equipment to
measure oxygen saturation and distance during walking tests
and carried out 47 exercise tests over the same period.
Furthermore, in two smaller paediatric clinics (∼35 patients)
one clinic conducted 34 and the other clinic only 2 exercise tests
over 12 months. Both had the same equipment availability,
assigned the same level of importance to exercise testing, and
stated that the availability of personnel did not limit exercise
testing.
The majority of UK clinics do not have the resources to
measure V̇O2peak (i.e., availability of metabolic gas analysis
system with treadmill or cycle ergometer), which is the most
precise method of assessing physical fitness in healthy
individuals with mild disease and normal exercise tolerance,
as it directly measures oxygen transportation to and utilisation
by the working muscles. Walking tests, however, are more
commonly used and offer a simple and inexpensive means of
assessing exercise limitation. The six-minute walking test has
been shown to correlate with V ̇O2peak in children with severe
and moderate disease, [18,19] but, it does not accurately predict
the V ̇O2peak of the patient. In early disease the correlation
between exercise limitation assessed by V̇O2peak and lung high
resolution computed tomographic (HRCT) abnormalities, such
as mucus plugging, is stronger than that between spirometry
results, or BMI and exercise limitation [20]. Also, spirometric
lung function can remain stable or improve when HRCT scores
deteriorate [21] and in mild disease spirometry is not a strong
predictor of V̇O2peak [22]. Therefore, there is a greater need to
direct by measure of V̇O2peak through exercise testing.
The UK Cystic Fibrosis Trust (2001) recommended exercise
testing should be performed on an annual basis, and exercise
programmes should be tailored to the individual, taking into
consideration disease severity, level of fitness and the patient's
preferences to exercise activities [11]. The British Thoracic
Society and the Association of Chartered Physiotherapists in
Respiratory Care (2009) recommends that exercise should be an
integral part of CF care with training that achieves the minimum
activity levels detailed in the American College of Sports
Medicine guidelines [23]. Studies have reported that most
children and adolescents with CF engage in physical activities
at a comparable level to their healthy peers [24,25]. However,
determining what is best suited to specific disease phenotypesrequires further research and individuals may require a tailored
regimen to ensure adherence.
In conclusion, this survey shows, that UK practice falls short
of recommendations due to both resource limitations and in a
minority of clinics due to the opinion that exercise assessments
[4 (4.2%)] and training [2 (2.1%)] are unimportant. Generally,
however, in the UK, like Germany, there is a discrepancy
between the high importance given to the value of exercise by
healthcare providers and what is available. Physical fitness and
survival are strongly associated and the potential exercise
training has to increase physical fitness in patients with CF
means standardisation of training in clinics could improve
clinical outcomes. More sophisticated objective measures of
exercise performance e.g., aerobic capacity, which is not widely
available, may offer a tool for monitoring disease activity and
help evaluate the benefit of therapeutic interventions in early
disease where lung function is not sensitive.Conflict of interest
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